Manufacturing facility
Zydus Pharmaceuticals Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Sub Plot No. - 20 & 21, Pharmez - Special Economic Zone, Sarkhej Bavla Road N.H. No. 8A Village.- Matoda, Taluka. - Sanand 382213 Ahmedabad, Matoda, Gujarat 382213, India (IND)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3022238550 · DUNS 650173735
Drugs this plant is listed as making
10 distinct drugs across 60 products name this site in their FDA label.
- atorvastatin calciumZydus Pharmaceuticals USA Inc.
- CarvedilolZydus Pharmaceuticals USA Inc.
- Cevimeline HydrochlorideViona Pharmaceuticals Inc
- DapsoneZydus Lifesciences Limited
- gabapentinZydus Lifesciences Limited
- Losartan PotassiumZydus Lifesciences Limited
- Methenamine hippurateZydus Lifesciences Limited
- Sertraline HydrochlorideZydus Pharmaceuticals (USA) Inc.
- Trazodone HydrochlorideZydus Pharmaceuticals USA Inc.
- ValsartanZydus Lifesciences Limited
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.